Meningococcal carriage and disease--population biology and evolution
- PMID: 19464092
- PMCID: PMC2719693
- DOI: 10.1016/j.vaccine.2009.04.061
Meningococcal carriage and disease--population biology and evolution
Abstract
Meningococcal disease occurs worldwide with incidence rates varying from 1 to 1000 cases per 100,000. The causative organism, Neisseria meningitidis, is an obligate commensal of humans, which normally colonizes the mucosa of the upper respiratory tract without causing invasive disease, a phenomenon known as carriage. Studies using molecular methods have demonstrated the extensive genetic diversity of meningocococci isolated from carriers, in contrast to a limited number of genetic types, known as the hyperinvasive lineages, associated with invasive disease. Population and evolutionary models that invoke positive selection can be used to resolve the apparent paradox of virulent lineages persisting during the global spread of a non-clonal and normally commensal bacterium. The application of insights gained from studies of meningococcal population biology and evolution is important in understanding the spread of disease, as well as in vaccine development and implementation, especially with regard to the challenge of producing comprehensive vaccines based on sub-capsular antigens and measuring their effectiveness.
Similar articles
-
Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.J Clin Microbiol. 2014 Jun;52(6):1901-10. doi: 10.1128/JCM.03584-13. Epub 2014 Mar 19. J Clin Microbiol. 2014. PMID: 24648565 Free PMC article.
-
Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.J Clin Microbiol. 2012 Feb;50(2):264-73. doi: 10.1128/JCM.05385-11. Epub 2011 Nov 30. J Clin Microbiol. 2012. PMID: 22135261 Free PMC article.
-
Lessons from meningococcal carriage studies.FEMS Microbiol Rev. 2007 Jan;31(1):52-63. doi: 10.1111/j.1574-6976.2006.00052.x. FEMS Microbiol Rev. 2007. PMID: 17233635 Review.
-
Neisseria meningitidis; clones, carriage, and disease.Clin Microbiol Infect. 2014 May;20(5):391-5. doi: 10.1111/1469-0691.12647. Clin Microbiol Infect. 2014. PMID: 24766477 Review.
-
Neisseria meningitidis: an overview of the carriage state.J Med Microbiol. 2004 Sep;53(Pt 9):821-832. doi: 10.1099/jmm.0.45529-0. J Med Microbiol. 2004. PMID: 15314188 Review.
Cited by
-
Characterizing the diversity and commensal origins of penA mosaicism in the genus Neisseria.Microb Genom. 2024 Feb;10(2):001209. doi: 10.1099/mgen.0.001209. Microb Genom. 2024. PMID: 38381035 Free PMC article.
-
Microevolution and Its Impact on Hypervirulence, Antimicrobial Resistance, and Vaccine Escape in Neisseria meningitidis.Microorganisms. 2023 Dec 18;11(12):3005. doi: 10.3390/microorganisms11123005. Microorganisms. 2023. PMID: 38138149 Free PMC article. Review.
-
Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis.Med Sci (Basel). 2023 Dec 1;11(4):76. doi: 10.3390/medsci11040076. Med Sci (Basel). 2023. PMID: 38132917 Free PMC article.
-
Neisseria meningitidis accumulate in large organs during meningococcal sepsis.Front Cell Infect Microbiol. 2023 Nov 28;13:1298360. doi: 10.3389/fcimb.2023.1298360. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38089821 Free PMC article.
-
Sphingosine kinase 1/S1P receptor signaling axis is essential for cellular uptake of Neisseria meningitidis in brain endothelial cells.PLoS Pathog. 2023 Nov 30;19(11):e1011842. doi: 10.1371/journal.ppat.1011842. eCollection 2023 Nov. PLoS Pathog. 2023. PMID: 38033162 Free PMC article.
References
-
- Griffiss J.M., Brandt B., Jarvis G.A. Natural immunity to Neisseria meningitidis. In: Vedros N.A., editor. vol. II. CRC Press; Boca Raton: 1987. pp. 99–119. (Evolution of meningococcal disease).
-
- Olcen P., Kjellander J., Danielsson D., Lindquist B.L. Epidemiology of Neisseria meningitidis, prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis. 1981;13(2):105–109. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
